Related Companies
|
[]
|
||||||||
Related Funds
|
[]
|
||||||||
English
|
|||||||||
|
|||||||||
oda_CreditRatingAbstract|
|
|
||||||||
oda_UpdateAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
oda_CorrectionAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
oda_DateOfThePreviousNotificationAboutTheSameSubject|
|
|
-
|
|||||||
oda_DelayedAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
oda_AnnouncementContentSection|
|
|
||||||||
oda_ExplanationSection|
|
|
||||||||
oda_ExplanationTextBlock|
|
Following its periodic annual review of the corporate credit rating, JCR Eurasia Rating evaluated the consolidated structure of MLP Sağlık Hizmetleri ("Company") and the bond issuances in an investment level category on a national and international level. JCR upgraded the ratings on the Long Term and Short Term National Scales to "BBB+(Trk)" and "A-2(Trk)", respectively, and affirmed the "Stable" outlook. Additionally, the Long Term International Foreign and Local Currency Ratings have been affirmed at the country ceiling level of "BBB-". In the rating report, factors including high levels of revenue growth in all segments and increasing EBITDA/EBITDAR margn, improving equity-liability composition and debt service coverage capacity post IPO, the improvement in compliance with Corporate Governance Practices and transparency, expected contribution of the rapidly growing revenues derived from the top-up insurance and medical tourism segments were stated as the principle factors underlying the upgrade of the Company's Long Term National Ratings. |
We proclaim that our above disclosure is in conformity with the principles set down in “Material Events Communiqué” of Capital Markets Board, and it fully reflects all information coming to our knowledge on the subject matter thereof, and it is in conformity with our books, records and documents, and all reasonable efforts have been shown by our Company in order to obtain all information fully and accurately about the subject matter thereof, and we’re personally liable for the disclosures.